Christoph Zielinski - Researcher Profile

Publications

3 shown

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

Tudor‐Eliade Ciuleanu , Thomas Brodowicz , Christoph Zielinski +16 more

2009 The Lancet 1111 citations

Supplementary Data from Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

Ann-Sofie Schmolke , Ilse Schwarzinger , Edgar Selzer +67 more

<p>Supplementary Data containing the statistical analysis plan, Supplemental Figures 1-6 and Supplemental Tables 1 and 2</p>

2025 0 citations

Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.

Yuri Agrawal , Aranzazu Fernández-Martínez , Miguel Gil‐Gil +26 more

PURPOSE: For hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer (MBC), first-line cyclin-dependent kinase 4/6 inhib...

2025 UNC Libraries 0 citations

Frequent Co-Authors

Researcher Info

h-index: 1
Publications: 3
Citations: 1,111
Institution: Central European Cooperative Oncology Group

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-1440-9013

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.